Literature DB >> 10193686

A practical guide to the management of oesophageal varices.

G McCormack1, P A McCormick.   

Abstract

Bleeding oesophageal varices are a frequent and sometimes fatal complication of portal hypertension. Prompt resuscitation and arrest of haemorrhage are the immediate short term priorities. Vasoactive therapy to reduce portal pressure is administered on presentation. Early endoscopy is necessary to make a definitive diagnosis and initiate appropriate therapy; usually emergency sclerotherapy or banding. After the acute bleeding episode, follow-up therapy is instituted either to obliterate the varices by sclerotherapy or banding, or to chronically lower portal pressure and hence reduce the risk of bleeding pharmacologically; a combination of both strategies may be also used. Active surveillance of those at risk of developing varices is advocated. Long term beta-blocker therapy has been demonstrated to be effective in both the primary prevention of variceal haemorrhage and the prevention of rebleeding in those who have already bled. Despite a multitude of therapeutic regimes and ongoing clinical trials, mortality from this condition remains disappointingly high.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193686     DOI: 10.2165/00003495-199957030-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  37 in total

1.  Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial.

Authors: 
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

2.  Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices.

Authors:  R J Polson; D Westaby; A E Gimson; P C Hayes; A J Stellon; K Hayllar; R Williams
Journal:  Hepatology       Date:  1989-09       Impact factor: 17.425

3.  Recent advances in the endoscopic management of variceal bleeding.

Authors:  S G Williams; D Westaby
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

4.  Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial.

Authors:  A Avgerinos; F Nevens; S Raptis; J Fevery
Journal:  Lancet       Date:  1997-11-22       Impact factor: 79.321

5.  A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage.

Authors:  S A Jenkins; R Shields; M Davies; E Elias; A J Turnbull; M F Bassendine; O F James; J P Iredale; S K Vyas; M J Arthur; A N Kingsnorth; R Sutton
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

6.  Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy.

Authors:  P A McCormick; G L Kaye; L Greenslade; F Cardin; K E Hobbs; N McIntyre; A K Burroughs
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

Review 7.  Review article: the transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension.

Authors:  P A McCormick; R Dick; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  1994-06       Impact factor: 8.171

8.  Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding.

Authors:  A K Burroughs; P A McCormick; M D Hughes; D Sprengers; F D'Heygere; N McIntyre
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

9.  Propranolol--a medical treatment for portal hypertension?

Authors:  D Lebrec; O Nouel; M Corbic; J P Benhamou
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

10.  Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications. Double-blind randomized study.

Authors:  P K Garg; S S Sidhu; D K Bhargava
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

View more
  2 in total

1.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

2.  Beneficial effects of living-donor liver transplantation on esophageal varices.

Authors:  Tomokazu Kawaoka; Shoichi Takahashi; Hiroshi Aikata; Takahiro Azakami; Hiromi Saneto; Shintaro Takaki; Soo Cheol Jeong; Toshimasa Asahara; Katsuhide Ito; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.